GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ELEV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Elevation Oncology, Inc. stock after losing 3.14%
(Updated on Apr 18, 2024)

Sell candidate since Apr 15, 2024 Loss -9.48% PDF

The Elevation Oncology, Inc. stock price fell by -3.14% on the last day (Thursday, 18th Apr 2024) from $4.14 to $4.01. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 4.92% from a day low at $3.96 to a day high of $4.16. The price has fallen in 8 of the last 10 days and is down by -20.75% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -177 thousand shares and in total, 319 thousand shares were bought and sold for approximately $1.28 million.

Given the current short-term trend, the stock is expected to rise 89.21% during the next 3 months and, with a 90% probability hold a price between $7.59 and $10.68 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ELEV Signals & Forecast

There are few to no technical positive signals at the moment. The Elevation Oncology, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.46 and $4.61. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -22.44%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Elevation Oncology, Inc. stock

Elevation Oncology, Inc. finds support from accumulated volume at $3.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.195 between high and low, or 4.92%. For the last week the stock has had daily average volatility of 8.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ELEV) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Elevation Oncology, Inc. to open at $4.04, and during the day (based on 14 day Average True Range), to move between $3.59 and $4.43, which gives a possible trading interval of +/-$0.417 (+/-10.40%) up or down from last closing price. If Elevation Oncology, Inc. takes out the full calculated possible swing range there will be an estimated 20.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.85 (3.99%) than the resistance at $4.50 (12.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Elevation Oncology, Inc. stock A Buy?

The Elevation Oncology, Inc. stock holds several negative signals and despite the positive trend, we believe Elevation Oncology, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.537 Sell Candidate Unchanged

Predicted Opening Price for Elevation Oncology, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$4.04 ( 0.790%) $4.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ELEV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.24 5.65 %
R2 4.16 3.79 %
R1 4.12 2.65 %
Current price: 4.01
Support S1 3.97 -1.07 %
S2 3.92 -2.22 %
S3 3.85 -4.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.01 24.94 %
R2 4.67 16.46 %
R1 4.50 12.22 %
Current price 4.01
Support S1 3.85 -3.99%
S2 3.71 -7.48%
S3 3.02 -24.69%

FAQ

What is the symbol for Elevation Oncology, Inc. Stock and on which exchange is it traded?
The symbol for Elevation Oncology, Inc. is ELEV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Elevation Oncology, Inc. Stock?
The Elevation Oncology, Inc. stock holds several negative signals and despite the positive trend, we believe Elevation Oncology, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Elevation Oncology, Inc. Stock?
Elevation Oncology, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Elevation Oncology, Inc. Stock.

What's the current price of Elevation Oncology, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Elevation Oncology, Inc. (ELEV) share was $4.01.

What is the 52-week high and low for Elevation Oncology, Inc. Stock?
The 52-week high for Elevation Oncology, Inc. Stock is $5.89 and the 52-week low is $0.363.

What is the market capitalization of Elevation Oncology, Inc. Stock?
As of the 2024-04-18, the market capitalization of Elevation Oncology, Inc. is 201.416M.

When is the next earnings date for Elevation Oncology, Inc.?
The upcoming earnings date for Elevation Oncology, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Elevation Oncology, Inc.

Elevation Oncology. Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas... ELEV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT